Disseminated intravascular coagulation: What's new?

Related Experiment Video

Updated: Aug 17, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Marcel Levi1

  • 1Department of Vascular and Internal Medicine (F-4), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. m.m.levi@amc.uva.nl

Critical Care Clinics
|July 5, 2005
PubMed

Insights

Disseminated intravascular coagulation (DIC) is a critical condition involving systemic coagulation activation, fibrin deposition, and consumption of clotting factors. Understanding its pathways informs new anticoagulant and pathway restoration therapies.

Area of Science:

  • Hematology
  • Pathophysiology
  • Medical Science

Background:

  • Disseminated intravascular coagulation (DIC) is a complex syndrome.
  • It involves systemic coagulation activation, leading to fibrin deposition in microvasculature.
  • This process consumes coagulation factors and platelets, linking DIC to organ dysfunction.

Purpose of the Study:

  • To elucidate the pathogenetic mechanisms of DIC.
  • To highlight the role of microvascular thrombosis in organ dysfunction.
  • To discuss novel therapeutic strategies for DIC.

Main Methods:

  • Review of pathological, experimental, and clinical findings.
  • Analysis of pathogenetic pathways including coagulation activation, anticoagulant pathways, and fibrinolysis.
  • Evaluation of emerging therapeutic approaches.

Main Results:

  • DIC pathogenesis involves tissue factor-dependent coagulation activation.
  • Defects in physiological anticoagulant pathways (antithrombin, protein C) contribute to DIC.
  • Impaired fibrinolysis, due to elevated plasminogen activator inhibitor type 1, is also implicated.

Conclusions:

  • Insights into DIC pathogenesis are driving novel therapeutic strategies.
  • Therapeutic approaches include anticoagulation targeting tissue factor.
  • Restoring physiological anticoagulant pathways, such as with activated protein C concentrate, is a key strategy.

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.